Latisse, Lumigan, and The Path to Eyelash Enhancement
In the recent past, we’ve seen many drugs make their way to the market inadvertently, becoming hugely popular for uses that were never intended; such is the case with Latisse, Allergan’s new eyelash enhancement drug.
Latisse was born out of a group of popular medications called topical prostaglandins, drugs frequently used to decrease intra-ocular pressure in glaucoma patients. What optometrists labeled a ‘complication’ or side effect of using prostaglandins was “hypertrichosis,” a condition characterized by darkening, thickening, and lengthening of the eyelashes.
Allergan offered the topical prostaglandin Lumigan in 2001, a drug that contained the active ingredient bimatoprost. Two important precursors to Latisse occurred after the FDA gave clearance for Lumigan.
Jan Marini Skin Research Inc had over $2 million worth of product seized by the Food and Drug Administration. The product, Age Intervention Eyelash, evidently contained bimatoprost, which was unapproved for cosmetic use at the time. Allergan later filed a patent infringement suit against Jan Marini and several other companies that had tried to market bimatoprost in their eyelash enhancing drugs.
Some doctors started prescribing Lumigan off-label to enhance eyelashes. Knowing the desirable side effects it could produce. But Lumigan wasn’t formulated for cosmetic use and many believed more research was needed to confirm the safety of topical prostaglandins for cosmetic use.
Clinical trials and further research is exactly what Allergan Inc did. In one early study, 278 healthy adults with minimal to moderate eyelash prominence applied bimatoprost or a placebo to their lash line. The results were favorable; researchers observed that the average patient’s eyelashes were 25 percent longer, 106 percent fuller, and 18 percent darker, while only 3.6 percent experienced itchy eyes and redness, and only 2.9 percent experienced skin hyperpigmentation.
Latisse received FDA approval late last year for the treatment of ‘inadequate’ eyelashes. Allergan now owns the patent on use of bimatoprost for eyelash enhancement.
For more information on Latisse in Indiana, contact us.
July 2nd, 2010 at 12:49 am
every time I used false eye lashes it irritates my eyes so I decided to look for a lash growth product. Only me found out about revitalash thru research at the net and bought one thru net also. I followed the instruction and since then I noticed the difference of my lashes, its now long thick and fuller. It looks natural! Thanks for my curiosity.
July 8th, 2010 at 2:16 pm
I’ll definitely go for revitalash eyelash conditioner for my eyelashes. I’ve been doing an online research to answer the problem of my dull and short lashes, then most good reviews are for revitalash. Thanks for the information. I’ll be going to get one this week and see it for myself. any suggestions?
July 10th, 2010 at 11:02 am
I absolutely believe in this product revitalash because I deliberately used it on my bottom lashes to see if I had any improvement on lashes that had not been damaged by extensions and I’ve proven its effectivity in making lash long and thick. I will continue to use this product as part of my beauty regime
July 16th, 2010 at 2:18 am
I have used revitalash for over 2 months and have had no adverse reaction other than my lashes had started to grow longer and thicker, much better than before
July 16th, 2010 at 8:13 am
Read about those review about Revitalash. Since is not expensive, so decided to give a try. I must say after 3 weeks I actually can see my eyelashes look longer and healthier. Will keep you guys posted 3 weeks from now on the result.